git 6-csbrp
TRANSCRIPT
Inflammatory Bowel DiseaseInflammatory Bowel Disease
Dr.CSBR.Prasad, M.D.,
May-2015-CSBRP
CaseCase
• 17yo complains of pain abdomen and h/o passage of blood and mucus in his stool since 5months
• He gives a h/o spontaneous remissions
What are your differentials?
May-2015-CSBRP
Case – continued….Case – continued….
• Stool examination: – Shows Mucus, RBCs & Pus cells – Negative for ova and parasites– Cultures: Repeatedly negative for pathogens
What are your differentials?
May-2015-CSBRP
Possible diagnosis:
• Inflammatory bowel disease
May-2015-CSBRP
Inflammatory Bowel DiseaseInflammatory Bowel DiseaseIBDIBD
May-2015-CSBRP
May-2015-CSBRP
IBDIBD
• Def: IBD is a immune mediated chronic inflammatory condition of intestines
• Major types:– Ulcerative colitis (UC)– Crohn’s disease (CD)
Indeterminate colitis (IC):• In 15% of IBD patients it’s impossible to differentiate
UC from CD. They are designated as IC
May-2015-CSBRP
Epidemiology of IBD
May-2015-CSBRP
Pathogenesis
May-2015-CSBRP
May-2015-CSBRP
Pathogenesis
Current concept:• Inappropriate immune response to the
endogenous commensal microbiota with in the intestine with / without some component of autoimmunity
May-2015-CSBRP
Pathogenesis – genetic factors• IBD is a polygenic disorder• More than 100 disease associated loci on
different chromosomes• 1/3rd of them overlap (UC & CD)• Genetic risk factors for IBD are also seen in
other immune mediated diseases– RA (TNF A IP3)– SLE (TNF A IP3)– Psoriasis (IL 23R, IL 12B)– Ankylosing spondilitis (IL 23R)– Type-I DM (IL 10, PTPN2)
May-2015-CSBRP
Pathogenesis – genetic factors
May-2015-CSBRP
Pathogenesis – genetic factors
May-2015-CSBRP
Primary genetic disorder associated with IBD
Psoriasis
Ankylosing spondylitis
Primary sclerosing cholangitis
PathogenesisOral tolerance:• Mucosal immune system is normally unreactive
to luminal contents due to “Oral tolerance”• Mechanisms:
– Deletion / anergy of Ag reactive T-cells– Induction of CD4+ T-cells that suppresses gut
inflammation– By secreting IL10 & TGF-beta
• In IBD oral tolerance is altered resulting in uncontrolled inflammation
May-2015-CSBRP
Pathogenesis
May-2015-CSBRP
Pathogenesis – Exogenous factors
1. Multiple pathogens have been implicated• Salmonella• Shigella• Campylobacter• Clostridium difficile May trigger an inflammatory response that then
goes unregulated2. Psychosocial factors
May-2015-CSBRP
Ulcerative colitis (UC)Ulcerative colitis (UC)
May-2015-CSBRP
Pathology – UC
• Always involve rectum• Extends proximally to involve all / part of
colon– 40-50% rectum / sigmoid– 30-40% beyond sigmoid– 20% total colitis– “Backwash ileitis”
May-2015-CSBRP
Pathology – UC• Mild inflammation: the mucosa is erythematous
with fine granular surface – sandpaper• More severe disease: the mucosa is
hemorrhagic, edematous, and ulcerated• In long-standing disease: inflammatory polyps
(pseudopolyps) • in Remission: The mucosa may appear normal• Patients with fulminant disease:
– Toxic colitis or megacolon – Ulceration– Perforation
May-2015-CSBRP
Ulcerative colitis
May-2015-CSBRP
Pan-ulcerative colitisM
ay-2
015-
CS
BR
P
Pan-ulcerative colitis
May-2015-CSBRP
Pan-ulcerative colitis
May-2015-CSBRP
Inflamed colonic mucosa demonstrating pseudopolyps in a patient with ulcerative colitis
May-2015-CSBRP
Thinned out wall, ulcers, pseudopolyps
May-2015-CSBRP
Serpigenous ulcers, mucosal bridges and pseudopolyps
May-2015-CSBRP
UC - pseudopolyps
May-2015-CSBRP
Ulcers confined to mucosa
May-2015-CSBRP
Marked lymphocytic infiltration of the intestinal mucosa and architectural distortion of the crypts
May-2015-CSBRP
Chronic architectural changes in ulcerative colitis. Note the crypt branching and irregularity of size and shape, with an increase in chronic inflammatory cells in the lamina propria
May-2015-CSBRP
Crypt abscess
May-2015-CSBRP
UC – Clinical features• Diarrhea• Rectal bleeding• Tenesmus• Passage of mucus• Crampy abdominal pain• Anorexia, nausea, vomiting• Weight loss• o/e tender anal canal, blood on PR• Complications:
– Toxic megacolon– Perforation– Peritonitis– Strictures (mimic carcinoma)– Carcinoma
May-2015-CSBRP
Adenocarcinoma in UC
May-2015-CSBRP
Patients with ulcerative colitis can occasionally have aphthous ulcers involving the tongue, lips, palate and pharynx
May-2015-CSBRP
Crohn’s disease (CD)Crohn’s disease (CD)
1884-1983
May
-201
5-C
SB
RP
Pathology - CD• Can affect any part of the gastrointestinal tract
– 30–40% small-bowel disease (75% terminal ileum)– 40–55% both the small and large intestines, and – 15–25% have colitis alone– Rectum is often spared
• “Skip areas” in the midst of diseased intestine • Perirectal fistulas, fissures, abscesses, and • Anal stenosis are present in 1/3rd of patients• Rarely, may involve the liver and the pancreas
May-2015-CSBRP
Morphology
• Involved segment is rubbery and thick (due to edema, inflammation, fibrosis and hypertrophied muscularis propria)
• String sign in X-ray• Skip lesions• Cobble stone mucosa• Deep penetrating ulcers• Fistulae
May-2015-CSBRP
‘Cobble stone’ appearance
May-2015-CSBRP
‘Cobble stone’ appearance
May-2015-CSBRP
Creeping fat
May-2015-CSBRP
May-2015-CSBRP
Stenosis of terminal ileum
May-2015-CSBRP
‘String sign’ – very thin luminal constrast in the terminal ileum
May-2015-CSBRP
Double-contrast barium enema study demonstrates marked ulceration, inflammatory changes, and narrowing of the
right colon in a patient with Crohn colitis
May-2015-CSBRP
May-2015-CSBRP
May-2015-CSBRP
May-2015-CSBRP
Enterocolic fistula of Crohn's diseaseThe barium study outlines the fistula connecting
the small bowel to the colon
May-2015-CSBRP
Morphology
• Neutrophils in isolated crypts• Architectural distortion
– Villous blunting– Atophy– Metaplasia
• Transmural inflammation• Non-caseating granulomas• Submucosal fibrosis• Thickening of muscularis propria• Strictures
May-2015-CSBRP
Deep penetrating ulcers
May-2015-CSBRP
Deep knifelike, fissuring, transmural ulcer in Crohn disease
May
-201
5-C
SB
RP
Transmural inflammation
May-2015-CSBRP
Non-caseating granulomas
May-2015-CSBRP
CD – Clinical features
• Site of the disease influences the clinical manifestations
• Patterns:1. Fibrostenotic obstructive pattern2. Penetrating fistulous pattern
May-2015-CSBRP
The three most common sites of intestinal
involvement in Crohn's disease:
ileojejunalileocolic and
colonic
May-2015-CSBRP
CD – Clinical featuresIleocolitis:• Right lower quadrant pain• Pain releived by defecation• Weight loss• String sign in X-ray• Fistulae • Microperforations Colitis / perianal disease:• Strictures• Fistulae
Jejunoileitis:• Malabsorption
– Anemia– Hypoalbuminemia– Hypocalcemia– Coagulopathy
• Nutritional deficiency– Pellagra– Osteoporosis– Megaloblastic anemia– Neurological symptoms
May-2015-CSBRP
CD – Clinical features
Fistulae:• Duodenocolic (fecal vomitus)• To mid small bowel (short circuiting - malabsorption)• Rectovaginal (feculent vaginal discharge esp. after
hystrectomy)• Enterovesicle (fecaluria, pneumaturia)• Enterocutaneous • Perianal disease (fistulae, fissures)
May-2015-CSBRP
Complications
• Serosal adhesions• Perforations• Peritonitis• Intraabdominal / pelvic abscesses• Perianal disease• Obstruction
May-2015-CSBRP
May-2015-CSBRP
Patients with Crohn’s disease can occasionally have aphthous ulcers involving the tongue, lips, palate and pharynx
May-2015-CSBRP
Feture Crohn’s disease Ulcerative colitis
MacroscopicMacroscopicSite Ileum +/- colon Colon only
Distribution Skip lesions Diffuse
Strictures Early Late
Wall appearance Thickened Thin
Dilatation No Yes
MicroscopicMicroscopicPseudopolyps No Marked
Ulcers Deep linear Superficial
Lymphoid reaction Marked Mild
Granulomas Present Absent
Fibrosis Marked Mild
Fistulae/sinuses Present Absent
ClinicalClinicalMalabsorptions Yes No
Malignant potential Yes Yes
Response to surgery Poor Good
May
-201
5-C
SB
RP
E N D
May-2015-CSBRP
Introduction – “Oral toleranceOral tolerance”
• Entry of pathogen is associated with production of:– Antibodies or– Activated lymphocytes
• Sites where bacteria are present normally in the body as commensals:– Skin– Oropharynx– Large intestine
• Reaction of our defences to normal commensals is inappropriate
Inflammation
No Inflammation
May-2015-CSBRP